New anticounterfeiting technology
A security technology, previously exclusively reserved for use by government organizations has become commercially available with major pharma manufacturers eager to adopt the device.
A security technology, previously exclusively reserved for use by government organizations has become commercially available with major pharma manufacturers eager to adopt the device. The product is expected to help fight against the counterfeit drugs market, a trade that is growing rapidly.
The Latentogram from ATB Security Technologies combines a holographic label incorporating a latent image, with a simple credit card-sized hand-held viewer. Looking at the hologram through the viewer reveals the hidden latent image, this establishing the authenticity of the product.
Despite not being as high-tech as other security products on the market, the product has advantages over other security devices. The cost of authenticating a product is reduced considerably, using only the hand-held reader, which is important for testing in developing countries where expensive security measures may not be available.
The technology allows the creation of textual and graphic images, photos and variable numeration within the hidden image.
Initial adoption for the device has been mainly in Eastern Europe, but the company has been in talks with several large pharmaceutical companies in the US.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
